PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
Visit https://www.peervoice.com/XEK860 to view the entire programme with slides. After completing “Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias”, participants will be able to: Summarise the burden of anaemia and thrombocytopenia in patients with myelofibrosis (MF); Describe the benefits and limitations of current JAK inhibitors in the management of patients with myelofibrosis; and Propose how emerging therapies and regimens that may address anaemia/thrombocytopenia, constitutional symptoms, and splenomegaly may impact the future management of myelofibrosis in both JAK-inhibitor-naïve and JAK-inhibitor-experienced patients.